HOME >> BIOLOGY >> NEWS
Hepatitis C complicated by morphine withdrawal

Philadelphia, PAResearchers at the University of Pennsylvania have demonstrated that morphine withdrawal complicates hepatitis C by suppressing IFN-alpha-mediated immunity and enhancing virus replication. The paper by Wang et al., Morphine withdrawal enhances hepatitis C virus (HCV) replicon expression, appears in the November issue of The American Journal of Pathology and is accompanied by a commentary.

Hepatitis C virus (HCV) is common among intravenous drug users, with 70 to 80% of abusers infected in the United States. This high association has peaked interest in determining the effects of drug abuse, specifically opiates, on progression of the disease. The discovery of such an association would impact treatment of both HCV infection and drug abuse.

Dr. Wen-Zhe Ho has been interested in such interplay for some time. His laboratory has previously shown using cell culture that morphine enhances virus replication and inhibits IFN-alpha (a natural anti-viral factor produced by immune, as well as host cells, and the only one approved in recombinant form for treating HCV infection). To further these results, his lab has used a cell model system to determine the consequences of morphine withdrawal, which is a common recurring event in opioid users.

Chuan-Qing Wang and colleagues examined the effects of morphine withdrawal (MW) on HCV-infected cultured liver cells by exposing cells to the drug for four days followed by its removal. They also assessed the effects of using naloxone, to block the opioid receptors, in conjunction with drug removal, i.e. precipitated morphine withdrawal (PW). To measure HCV replication, they used a virus-like replicon that mimics the events that occur in liver cells and expression of viral RNA and proteins that HCV uses. Although the replicon does not produce the infectious virus, the HCV replicon system represents the best available system for examining the impact of opiates on HCV at the time of their r
'"/>

Contact: Audra E. Cox
acox@asip.org
301-634-7409
American Journal of Pathology
28-Oct-2005


Page: 1 2

Related biology news :

1. Hepatitis C helicase unwinds DNA in a spring-loaded, 3-step process
2. Hepatitis B drug can compromise HIV treatment
3. Hepatitis E takes a piggyback
4. New hope for Hepatitis C research
5. Hepatitis C therapy: Inhibiting newly discovered microDNA molecule
6. New insights into protein synthesis and Hepatitis C infections
7. Hepatitis B accounts for 40 percent of missing Asian women
8. Identification of a protein important for Hepatitis B replication
9. Identification of specific genes predicts which patients will respond to Hepatitis C treatment
10. Hepatitis C virus linked to non-Hodgkins lymphoma
11. Efficacy of once-daily Avelox for complicated abdominal infections highlighted at ICAAC

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/6/2020)... ... 06, 2020 , ... Sickle Cell Disease Association of America, Inc. ... improving the quality, safety, efficacy and cost of red blood cell (RBC) transfusion therapy, ... mission and meet its goals. In 2020 Hemanext will collaborate with SCDAA on its ...
(Date:5/1/2020)... ... April 30, 2020 , ... Flagship ... Corritori Consulting Inc., a biopharmaceutical and regulatory services advisor. The companies now deliver ... Flagship and Corritori are taking a collaborative approach to empower more confident and ...
(Date:4/30/2020)... ... April 28, 2020 , ... Pebble Labs USA Inc. , ... agriculture and aquaculture with the mission of improving global food security, announced today that ... ' Next Heroes in Food- and Ag-Tech ' virtual event, a global initiative to ...
Breaking Biology News(10 mins):
(Date:5/30/2020)... NEW YORK (PRWEB) , ... May 29, 2020 ... ... launch of Chief Medical Officer 360°, the first newsletter solely dedicated to the ... will capture a wide range of perspectives on the responsibilities, problem-solving, best practices ...
(Date:5/28/2020)... ... May 28, 2020 , ... The Security Industry Association ... as the 2020 winners of the Women in Biometrics Awards – a ... , Biometric Update and the SIA Women in Security Forum . ...
(Date:5/21/2020)... ... 21, 2020 , ... Threats to intellectual property, political pressure ... to conventional wisdom that says the coronavirus pandemic will generally benefit biopharmaceutical companies, ... the pandemic commercially weaker, dealing with delays in new product launches and with ...
(Date:5/21/2020)... ... May 19, 2020 , ... Eaton Square is pleased to announce its growth ... a biotechnology and medical technology-focused strategy and M&A advisory firm. , This is an ... linking US and Asia Pacific healthcare innovators with capital and investors. , Popper and ...
Breaking Biology Technology:
Cached News: